Skip to main content

Emerging Therapies for Multiple Myeloma

June 13, 2018

Topics Covered

We invite you to learn more about:

  • Treatment advances for multiple myeloma
  • Side-effects management
  • Long-term and late effects of treatment
  • The importance of shared decision making when discussing treatment


Larry D. Anderson, Jr, MD, PhD
Associate Professor of Internal Medicine
Director of Myeloma, Waldenström’s, and Amyloidosis Program
Attending, Hematologic Malgnancies/Blood and Marrow Transplantation Program
UT Southwestern Medical Center
Dallas, TX


Audio Replay

Program Materials

Program Support

Support for this program provided by Amgen, Bristol-Myers Squibb, Celgene, and Takeda Oncology.


< Back to Webcasts